This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Biodot, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations by Brian L. Kirk in Karyotyping Technology
Introduction
Brian L. Kirk is an accomplished inventor based in Carlsbad, CA (US). He has made significant contributions to the field of karyotyping through his innovative methods and techniques. With a total of 2 patents, Kirk's work has advanced the efficiency and accuracy of cell sample analysis.
Latest Patents
One of his latest patents focuses on the controlled printing of a cell sample for karyotyping. This patent outlines methods that involve matrix printing using on-the-fly printing or dispensing techniques. These methods allow for the precise spreading of cells within a sample on a surface, which is crucial for karyotyping and further analysis. The advantage of this approach is that it results in a uniform distribution of chromosomes on the substrate, facilitating easier identification and enhancing the efficiency of subsequent staining processes. This innovation also supports further analysis of stained chromosomes using microscopes or other imaging devices.
Career Highlights
Brian L. Kirk is associated with Biodot, Inc., where he continues to develop and refine his innovative techniques. His work has garnered attention for its potential to improve laboratory practices in genetic analysis.
Collaborations
Kirk has collaborated with notable colleagues, including Anthony V. Lemmo and Thomas C. Tisone. Their combined expertise contributes to the advancement of technologies in the field.
Conclusion
Brian L. Kirk's contributions to karyotyping technology exemplify the impact of innovation in scientific research. His patents not only enhance the accuracy of cell sample analysis but also pave the way for future advancements in genetic studies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile